Iovance Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.

About IOVA

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. 

CEO
Frederick G. Vogt
CEOFrederick G. Vogt
Employees
838
Employees838
Headquarters
San Carlos, California
HeadquartersSan Carlos, California
Founded
2007
Founded2007
Employees
838
Employees838

IOVA Key Statistics

Market cap
601.08M
Market cap601.08M
Price-Earnings ratio
-1.48
Price-Earnings ratio-1.48
Dividend yield
Dividend yield
Average volume
9.64M
Average volume9.64M
High today
$1.86
High today$1.86
Low today
$1.77
Low today$1.77
Open price
$1.84
Open price$1.84
Volume
6.83M
Volume6.83M
52 Week high
$12.51
52 Week high$12.51
52 Week low
$1.64
52 Week low$1.64

Analyst ratings

67%

of 12 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own IOVA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.